{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:36:18Z","timestamp":1781894178815,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Imaging and Behavior"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11682-017-9803-y","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T02:05:04Z","timestamp":1513303504000},"page":"75-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer\u2019s disease after 18\u00a0months of treatment with the cholinesterase inhibitors donepezil or galantamine"],"prefix":"10.1007","volume":"13","author":[{"given":"Yukihiko","family":"Shirayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"9803_CR1","unstructured":"American Psychiatric Association (1994). Diagnostic and statistic manual of mental disorders (DSN-IV-TR), 4th\u00a0edn., text rev). Washington DC: American Psychiatric Press."},{"key":"9803_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2010.09.021","volume":"33","author":"E Canu","year":"2012","unstructured":"Canu, E., Frisoni, G. B., Agosta, F., Pievani, M., Bonetti, M., & Filippi, M. (2012). Early and late onset Alzheimer\u2019s disease patients have distinct patterns of white matter damage. Neurobiology of Aging, 33, 1023\u20131033.","journal-title":"Neurobiology of Aging"},{"key":"9803_CR3","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.neurobiolaging.2014.03.009","volume":"35","author":"E Cavedo","year":"2014","unstructured":"Cavedo, E., Pievani, M., Boccardi, M., Galluzzi, S., Bocchetta, M., Bonetti, M., et al. (2014). Medial temporal atrophy in early and late-onset Alzheimer\u2019s disease. Neurobiology of Aging, 35, 2004\u20132012.","journal-title":"Neurobiology of Aging"},{"key":"9803_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/01.wnf.0000138636.42121.45","volume":"27","author":"R Ceravolo","year":"2004","unstructured":"Ceravolo, R., Volterrani, D., Toqnoni, G., Dell\u2019Aqnello, G., Manca, G., Kiferie, L., et al. (2004). Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. Clinical Neuropharmacology, 27, 166\u2013170.","journal-title":"Clinical Neuropharmacology"},{"key":"9803_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jmri.23967","volume":"28","author":"S Chaudhart","year":"2013","unstructured":"Chaudhart, S., Scouten, A., Schwindt, G., Janik, R., Lee, W., Sled, J. G., et al. (2013). Hemodynamic effects of cholinesterase inhibition in mild Alzheimer\u2019s disease. Journal of Magnetic Resonance Imaging, 28, 26\u201335.","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"9803_CR6","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1006\/nimg.2002.1289","volume":"17","author":"B Desgranges","year":"2002","unstructured":"Desgranges, B., Baron, J. C., Giffard, B., Ch\u00e9telat, G., Lalev\u00e9e, C., de la Sayette, V., et al. (2002). The neural basis of instruction in free recall and cued recall: a PET study in Alzheimer\u2019s disease. Neuroimage, 17, 1658\u20131664.","journal-title":"Neuroimage"},{"key":"9803_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., et al. (2010). Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurology, 9, 1118\u20131127.","journal-title":"Lancet Neurology"},{"key":"9803_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/brain\/118.2.401","volume":"118","author":"PC Fletcher","year":"1995","unstructured":"Fletcher, P. C., Frith, C. D., Grasby, P. M., Shallice, T., Frackowiak, R. S., & Dolan, R. J. (1995). Brain systems for encoding and retrieval of auditory-verbal memory. An in vivo study in humans. Brain, 118, 401\u2013416.","journal-title":"Brain"},{"key":"9803_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinicians. Journal of Psychiatric Research, 12, 189\u2013198.","journal-title":"Journal of Psychiatric Research"},{"key":"9803_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/brain\/awl377","volume":"130","author":"GB Frisoni","year":"2007","unstructured":"Frisoni, G. B., Pievani, M., Testa, C., Sabattoli, F., Bresciani, L., Bonetti, M., et al. (2007). The topography of grey matter involvement in early and late onset Alzheimer\u2019s disease. Brain, 130, 720\u2013730.","journal-title":"Brain"},{"key":"9803_CR11","first-page":"S2-S10","volume":"14 suppl 1","author":"E Giacobini","year":"2000","unstructured":"Giacobini, E. (2000). Cholinestrase inhibitor therapy stabilize symptoms of Alzheimer disease. Alzheimer Disease and Associated Disorders, 14 suppl 1, S2-S10.","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"9803_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0028-3932(87)90118-7","volume":"25","author":"CL Grady","year":"1987","unstructured":"Grady, C. L., Haxby, J. V., Horwitz, B., Berg, G., & Rapoport, S. I. (1987). Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia, 25, 807\u2013816.","journal-title":"Neuropsychologia"},{"key":"9803_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., et al. (1975). Cerebral blood flow in dementia. Archives of Neurology, 32, 632\u2013637.","journal-title":"Archives of Neurology"},{"key":"9803_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jns.2009.10.022","volume":"290","author":"H Hanyu","year":"2010","unstructured":"Hanyu, H., Sato, T., Hirao, K., Kanetaka, H., Iwamoto, T., & Koizumi, K. (2010). The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer\u2019s disease: a longitudinal SPECT study. Journal of Neurological Sciences, 290, 96\u2013101.","journal-title":"Journal of Neurological Sciences"},{"key":"9803_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.neuroimage.2005.06.066","volume":"28","author":"K Hirano","year":"2005","unstructured":"Hirano, K., Ohnishi, T., Hirata, Y., Yamashita, F., Mori, T., Moriguchi, Y., et al. (2005). The prediction of rapid conversion of Alzheimer\u2019s disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage, 28, 1014\u20131021.","journal-title":"Neuroimage"},{"key":"9803_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1017\/S1041610213002573","volume":"26","author":"H Honda","year":"2014","unstructured":"Honda, H., Terada, S., Sato, S., Oshima, E., Ikeda, C., Nagao, S., et al. (2014). Subjective depressive mood and regional blood flow in mild Alzheimer\u2019s disease. International Psychogeriatrics, 26, 817\u2013823.","journal-title":"International Psychogeriatrics"},{"key":"9803_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1159\/000181148","volume":"26","author":"J Hongo","year":"2008","unstructured":"Hongo, J., Nakaaki, S., Shinagawa, Y., Murata, Y., Sato, J., Tatsumi, H., et al. (2008). SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer\u2019s disease. Dementia and Geriatric Cognitive Disorders, 26, 556\u2013566.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"9803_CR18","first-page":"333","volume":"26","author":"K Ishii","year":"2005","unstructured":"Ishii, K., Kawachi, T., Sasaki, H., Kono, A. K., Fukuda, T., Kojima, Y.,et al (2005). Voxel-based morphometric comparison between early- and late-onset mild Alzheimer\u2019s disease and assessment of diagnostic performance of Z score images. American Journal of Neuroradiology, 26, 333\u2013340.","journal-title":"American Journal of Neuroradiology"},{"key":"9803_CR19","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1212\/WNL.50.6.1563","volume":"50","author":"KA Johnson","year":"1998","unstructured":"Johnson, K. A., Jones, K., Holman, B. L., Spiers, P. A., Satllin, A., & Albert, M. S. (1998). Preclinical prediction of Altzheimer\u2019s disease using SPECT. Neurology, 50, 1563\u20131571.","journal-title":"Neurology"},{"key":"9803_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cortex.2015.10.014","volume":"74","author":"S Joubert","year":"2016","unstructured":"Joubert, S., Gour, N., Guedi, E., Didic, M., Gu\u00e9riot, C., Koric, L., et al. (2016). Early-onset and late-onset Alzheimer\u2019s disease are associated with distinct patterns of memory impaiment. Cortex, 74, 217\u2013232.","journal-title":"Cortex"},{"key":"9803_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/1533317512459798","volume":"27","author":"NC Kaiser","year":"2012","unstructured":"Kaiser, N. C., Melrose, R. J., Liu, C., Sultzer, D. L., Jimenez, E., Su, M., et al. (2012). Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer\u2019s disease. American Journal of Alzheimer\u2019s Disease and Other Dementias, 27, 520\u2013529.","journal-title":"American Journal of Alzheimer\u2019s Disease and Other Dementias"},{"key":"9803_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JAD-2010-101290","volume":"24","author":"C Keller","year":"2011","unstructured":"Keller, C., Kadir, A., Forsberg, A., Porras, O., & Noerberg, A. (2011). Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer\u2019s disease patients. Journal of Alzheimer\u2019s Disease, 24, 109\u2013123.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"9803_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/jnnp.74.6.715","volume":"74","author":"PM Kemp","year":"2003","unstructured":"Kemp, P. M., Holmes, C., Hoffmann, S. M., Bolt, L., Holmes, R., Rowden, J., et al. (2003). Alzheimer\u2019s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 715\u2013719.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"9803_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1552-6569.2011.00612.x","volume":"22","author":"N Kimura","year":"2012","unstructured":"Kimura, N., Kumamoto, T., Masuda, T., Hanaoka, T., Okazaki, T., & Arakawa, R. (2012). Evaluation of the cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer\u2019s disease using 3DSRT. Journal of Neuroimaging, 22, 299\u2013304.","journal-title":"Journal of Neuroimaging"},{"key":"9803_CR25","first-page":"1155","volume":"41","author":"D Kogure","year":"2000","unstructured":"Kogure, D., Matsuda, H., Ohnishi, T., Asada, T., Uno, M., Kunihiro, T., et al. (2000). Longitudinal evaluation of early Alzheimer\u2019s disease using brain perfusion SPECT. Journal of Nuclear Medicine, 41, 1155\u20131162.","journal-title":"Journal of Nuclear Medicine"},{"key":"9803_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nn.2321","volume":"12","author":"F Kouneiher","year":"2009","unstructured":"Kouneiher, F., Charron, S., & Koechlin, E. (2009). Motivation and cognitive control in the human prefrontal cortex. Nature Neuroscience, 12, 939\u2013945.","journal-title":"Nature Neuroscience"},{"key":"9803_CR27","first-page":"35","volume":"4","author":"A Kumar","year":"1991","unstructured":"Kumar, A., Schapiro, M. B., Grady, C., Haxby, J. V., Wagner, E., Salerno, J. A., et al. (1991). High-resolution PET studies in Alzheimer\u2019s disease. Neuropsychopharmacology, 4, 35\u201346.","journal-title":"Neuropsychopharmacology"},{"key":"9803_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00415-011-5927-y","volume":"258","author":"K Kume","year":"2011","unstructured":"Kume, K., Hanyu, H., Sato, T., Hirao, K., Shimizu, S., Kanetaka, H., et al. (2011). Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. Journal of Neurology, 258, 1295\u20131303.","journal-title":"Journal of Neurology"},{"key":"9803_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.JGP.0000214541.79965.2d","volume":"14","author":"DY Lee","year":"2006","unstructured":"Lee, D. Y., Choo, I. H., Jhoo, J. H., Kim, K. W., Youn, J. C., Lee, D. S., et al. (2006). Frontal dysfunction underlie depressive syndrome in Alzheimer disease: a FDG-PET study. American Journal of Geriatric Psychiatry, 14, 625\u2013628.","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"9803_CR30","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.neuroimage.2011.12.077","volume":"60","author":"W Li","year":"2012","unstructured":"Li, W., Antuono, P. G., Xie, C., Chen, G., Jones, J. L., Ward, B. D., et al. (2012). Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer\u2019s disease after 12-week donepezil treatment. Neuroimage, 60, 1083\u20131091.","journal-title":"Neuroimage"},{"key":"9803_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology, 34, 939\u2013944.","journal-title":"Neurology"},{"key":"9803_CR32","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima, S., Frey, K. A., Koeppe, R. A., Foster, N. L., & Kuhl, D. E. (1995). A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. Journal of Nuclear Medicine, 36, 1238\u20131248.","journal-title":"Journal of Nuclear Medicine"},{"key":"9803_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF02988523","volume":"17","author":"S Mizumura","year":"2003","unstructured":"Mizumura, S., Kumita, S., Cho, K., Ishihara, M., Nakajo, H., Toba, M., et al. (2003). Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Annals of Nuclear Medicine, 17, 289\u2013295.","journal-title":"Annals of Nuclear Medicine"},{"key":"9803_CR34","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","volume":"34","author":"C M\u00f6ller","year":"2013","unstructured":"M\u00f6ller, C., Vrenken, H., Jiskoot, L., Versteeg, A., Barkhof, F., Scheltens, P., et al. (2013). Different patterns of gray matter atrophy in early-and late-onset Alzheimer\u2019s disease. Neurobiology of Aging, 34, 2014\u20132022.","journal-title":"Neurobiology of Aging"},{"key":"9803_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000070851","volume":"50","author":"Y Nagahama","year":"2003","unstructured":"Nagahama, Y., Nabatame, H., Okina, T., Yamauchi, H., Narita, M., Fujimoto, N., et al. (2003). Cerebral correlations of the cognitive decline in probable Alzheimer\u2019s disease. European Neurology, 50, 1\u20139.","journal-title":"European Neurology"},{"key":"9803_CR36","first-page":"1441","volume":"41","author":"S Nakano","year":"2001","unstructured":"Nakano, S., Asada, T., Matsuda, H., Uno, M., & Takasaki, M. (2001). Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer\u2019s disease. Journal of Nuclear Medicine, 41, 1441\u20131445.","journal-title":"Journal of Nuclear Medicine"},{"key":"9803_CR37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S1388-2457(02)00110-4","volume":"113","author":"F Nobili","year":"2002","unstructured":"Nobili, F., Vitali, P., Canfora, M., Girtler, N., De Leo, C., Mariani, G., et al. (2002). Effects of long-term Donepezil therapy on rCBF of Alzheimer\u2019s patients. Clinical Neurophysiology, 113, 1241\u20131248.","journal-title":"Clinical Neurophysiology"},{"key":"9803_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/S1461145701002528","volume":"4","author":"SG Potkin","year":"2001","unstructured":"Potkin, S. G., Anand, R., Fleming, K., Alva, G., Keator, D., Carreon, D., et al. (2001). Brain metabolic and clinical effects of rivastigmine in Alzheimer\u2019s disease. International Journal of Neuropsychopharmacology, 4, 223\u2013230.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"9803_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1749-6632.1984.tb13859.x","volume":"435","author":"B Reisberg","year":"1984","unstructured":"Reisberg, B., Ferris, S. H., Anand, R., de Leon, M. J., Schneck, M. K., Buttinger, C., et al. (1984). Functional staging of dementia of the Alzheimer\u2019s type. Annals of the New York Academy of Sciences, 435, 481\u2013483.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"9803_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/brain\/107.3.811","volume":"107","author":"DP Roeltgen","year":"1984","unstructured":"Roeltgen, D. P., & Heilman, K. M. (1984). Lexical agraphia. Further support for the two-system hypothesis of linguistic agraphia. Brain, 107, 811\u2013827.","journal-title":"Brain"},{"key":"9803_CR41","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer\u2019s disease. American Journal of Psychiatry, 141, 1356\u20131364.","journal-title":"American Journal of Psychiatry"},{"key":"9803_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.conb.2007.03.001","volume":"17","author":"MF Rushworth","year":"2007","unstructured":"Rushworth, M. F., Buckley, M. J., Behrens, T. E., Walton, M. E., & Bennerman, D. M. (2007). Functional organization of the medial frontal cortex. Current Opinion of Neurobiology, 17, 220\u2013227.","journal-title":"Current Opinion of Neurobiology"},{"key":"9803_CR43","first-page":"81","volume":"14","author":"F S\u00e1","year":"2012","unstructured":"S\u00e1, F., Pinto, P., Cunha, C., Lemos, R., Letra, L., Sim\u00f5es, M., et al. (2012). Differences between early and late-onset Alzheimer\u2019s disease in neuropsychological tests. Frontiers in Neurology, 14, 81.","journal-title":"Frontiers in Neurology"},{"key":"9803_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000375527","volume":"5","author":"S Shimizu","year":"2015","unstructured":"Shimizu, S., Kanetake, H., Hirose, D., Sakurai, H., & Hanyu, H. (2015). Differential effects of acetylcholinesterase inhibitors on clinical responses and cerebral blod flow changes in patients with Alzheimer\u2019s disease: a 12-month, randomized, and open-label trial. Dementia and Geriatric Cognitive Disorders Extra, 5, 135\u2013146.","journal-title":"Dementia and Geriatric Cognitive Disorders Extra"},{"key":"9803_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00702-005-0312-6","volume":"113","author":"E Stefanova","year":"2006","unstructured":"Stefanova, E., Wall, A., Almkvist, O., Nilsson, A., Forsberg, A., L\u00e5ngstr\u00f6m, B., et al. (2006). Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer\u2019s disease. Journal of Neural Transmission, 113, 205\u2013218.","journal-title":"Journal of Neural Transmission"},{"key":"9803_CR46","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00702-017-1734-7","volume":"124","author":"M Takahashi","year":"2017","unstructured":"Takahashi, M., Oda, Y., Okubo, T., & Shirayama, Y. (2017). Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer\u2019s disease. Journal of Neural Transmission, 124, 1109\u20131121.","journal-title":"Journal of Neural Transmission"},{"key":"9803_CR47","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00234-008-0401-y","volume":"50","author":"M Tateno","year":"2008","unstructured":"Tateno, M., Kobayashi, S., Utsumi, K., Morii, H., & Fujii, K. (2008). Quantitative analysis of the effects of donepezil on regional cerebral blood flow in Alzheimer\u2019s disease by using an automated program, 3DSRT. Neuroradiology, 50, 723\u2013727.","journal-title":"Neuroradiology"},{"key":"9803_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF03027378","volume":"20","author":"Y Ushijima","year":"2006","unstructured":"Ushijima, Y., Okuyama, C., Mori, S., Kubota, T., Nakai, T., & Nishimura, T. (2006). Regional cerebral blood flow in Alzheimer\u2019s disease: comparison between short and long-term donepezil therapy. Annals of Nuclear Medicine, 20, 425\u2013429.","journal-title":"Annals of Nuclear Medicine"},{"key":"9803_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-015-0151-0","volume":"7","author":"N Verma","year":"2015","unstructured":"Verma, N., Beretvas, S. N., Pascual, B., Masdeu, J. C., & Markey, M. K. (2015). New scoring methodology improves the sensitivity of the Alzheimer\u2019s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials. Alzheimers Research & Therapy, 7, 64.","journal-title":"Alzheimers Research & Therapy"},{"key":"9803_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jnnp.57.3.285","volume":"57","author":"G Waldemar","year":"1994","unstructured":"Waldemar, G., Bruhn, P., Kristensen, M., Johnson, A., Paulson, O. B., & Lassen, N. A. (1994). Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99Tc]-d,l-HMPAO SPECT study. Journal of Neurology, Neurosurgery, and Psychiatry, 57, 285\u2013295.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"}],"container-title":["Brain Imaging and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-017-9803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11682-017-9803-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-017-9803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T22:19:57Z","timestamp":1569449997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11682-017-9803-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9803"],"URL":"https:\/\/doi.org\/10.1007\/s11682-017-9803-y","relation":{},"ISSN":["1931-7557","1931-7565"],"issn-type":[{"value":"1931-7557","type":"print"},{"value":"1931-7565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]},"assertion":[{"value":"15 December 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Shirayama has received research support from Eli Lilly, Eisai, MSD, Pfizer, Takeda and Mitsubishi-Tanabe. Dr. Iyo has received consultant fees from Eli Lilly, Sumitomo, Dainippon, Pfizer and Abbott.Drs. Takahashi, Oda, Yoshino and Sato have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ehical standards of the institutional research committee and with 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the ehics committee of Teikyo University Chiba Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}